|
mirVana™ Reagents and
Kits
MicroRNAs and Neural Stem Cell Differentiation
MicroRNAs (miRNAs) are key regulators of gene expression and
have been implicated in a variety of critical biological processes,
including development, cell differentiation, and oncogenesis.
To study this important class of small regulatory RNAs (19–23
nt in length), innovative and specialized tools are required.
The mirVana™ kits and reagents have been developed
to provide optimized solutions for miRNA isolation, expression
profiling, quantitative detection, and functional studies. This
article describes how Ambion’s complete suite of tools
was used to study the involvement of miRNA in neural stem cell
differentiation.
Yann Thomas, Sylvain Lehmann, and Ollivier Milhavet
Human Genetics Institute of Montpellier, Biology of Transmissible
Spongiform Encephalopathies Unit, 141 Cardonille Street, 34396
MONTPELLIER Cedex 5, FRANCE
|
|
|
Figure
1. Differential miRNA Expression During
Neuronal Differentiation. (A) Total
RNA was isolated with the mirVana™ miRNA
Isolation Kit from cultured mouse neural stem cells 0,
1, or 6 days (D0, D1, D6) after induction of neural progenitor
differentiation. miRNA expression was assessed by Northern
blot (10 µg total RNA) or by end point PCR (25
ng total RNA, 25 cycles) using the mirVana qRT-PCR
miRNA Detection Kit and appropriate Primer Sets. 5S rRNA
was used as a loading control. (B) The
relative change in miRNA expression at day 1 and 6 was
graphed according to the signal intensity at day 0 for
the three independent detection methods. Microarray expression
data were obtained after miRNA isolation with the flashPAGE™ Fractionator,
labelling of the miRNA fractions with the mirVana
miRNA Labelling Kit, and hybridization on microarrays
custom printed using the mirVana miRNA Probe
Set.
|
|
Model for Neural Development
Cultured stem cells from the central nervous system (CNS) have
proved useful in defining the pathways that lead to generation
of neurons and glia [1]. In culture, stem cells self-renew, and
after mitogen withdrawal, differentiate into neurons, astrocytes,
and oligodendrocytes in predictable proportions [1, 2]. Ex vivo,
single extrinsic factors can shift the fate of CNS stem cells
toward specific cell lineages [2, 3]. Based on these characteristics,
these cells have received increasing attention because of the
potential for their use in cell replacement or gene therapy.
Dr. Ollivier Milhavet and colleagues were interested in determining
whether miRNA expression is regulated during neural stem cell
differentiation and whether miRNA could be directly involved
in the differentiation process. To establish a model system to
study these questions, cortices were isolated from mouse embryos
(embryonic day 13.5) to create a monolayer culture of neural
stem cells [4]. Human recombinant basic fibroblast growth factor
(bFGF; 25 ng/ml) was added daily to stimulate expansion of the
proliferative precursors, and differentiation of the neural progenitors
was induced by withdrawing bFGF treatment.
miRNA Profiling of Differentiating Neural Stem
Cells
To identify potential variation of miRNA expression levels during
differentiation, expression profiles were determined with miRNA
arrays prepared from the mirVana miRNA Probe Set [5].
Total RNA was isolated from cortical cultures after 0, 1, or
6 days of differentiation, and following fractionation with the
flashPAGE™ System, the population of mature miRNAs at day 0 was
labeled using the mirVana miRNA Labeling Kit and compared
to labeled miRNA populations at days 1 or 6. Of the 161 miRNA
probes on the microarray, 39 miRNAs showed significant (at least
1.5 fold) differences in expression during neuronal differentiation.
Seven of the 39 miRNAs were chosen for further analysis (manuscript
in preparation).
Interestingly, different classes of miRNA were identified according
to tightly regulated expression patterns. Several miRNAs showed
steadily increasing or decreasing expression levels throughout
differentiation. Expression levels of others were strongly up-
or down-regulated at day 1, which by day 6 either remained unchanged
or returned to levels similar to day 0 (data not shown). These
observations suggest that different miRNAs may be involved in
specific cellular processes such as exit of cell cycle, neural
differentiation, or maintenance of the differentiated state.
|
|
|
Figure 2. Effect of Pre-miR™ and Anti-miR™ Molecules on Mouse Neuronal Differentiation. Pregnant female CD1 mice were sacrificed and cortices were dissected from embryos at day 13.5. Proliferative precursors were cultured for two days in the presence of bFGF and then electroporated with 5 µg of a specific Pre-miR miRNA Molecule or Anti-miR miRNA Inhibitor using Nucleofector® Technology (amaxa® Biosystems). bFGF was withdrawn from the culture medium to induce differentiation and cells were further grown for 6 days. Cell nuclei were stained with DAPI and differentiated neuronal cells were revealed by immunofluorescence with antibodies specific for bIII tubulin (Covance Research Products). As a control, nontransfected differentiated cells were also analyzed. A schematic representation of the observed neuronal bodies and dendrite extensions is shown under each picture. (See Figure 1 for expression pattern of this miRNA during differentiation.)
|
|
Profiling data were also confirmed by two independent detection
methods. An example of these validation tests for a specific
miRNA that showed a steady increase of expression throughout
differentiation according to the microarray analysis is shown
in Figure 1A. A direct comparison of the results showed very
good correlation among the three detection methods used (Figure
1B). As expected, the expression level of this miRNA, relative
to the internal control 5S rRNA, significantly increased at day
1 and at day 6 by Northern blot analysis and qRT-PCR (mirVana
qRT-PCR miRNA Detection Kit and Primer Sets).
Functional Analysis of Differentially Expressed
miRNAs
To further characterize these miRNAs, their expression levels
in neural stem cells were either augmented by electroporation
of Pre-miR™ miRNA Precursor Molecules or blocked by electroporation
of the corresponding Anti-miR™ miRNA Inhibitors. Cells were then
allowed to grow and differentiate after bFGF withdrawal for 6
additional days, and the impact on differentiation was assayed
by immunofluorescence experiments using specific cell markers
(e.g., neuronal marker bIII tubulin). When targeting an miRNA
that showed a strong increase in expression during differentiation
(see Figure 1), no differences were observed in the number of
neurons produced after either Pre-miR or Anti-miR treatment (Figure
2). However, Pre-miR miRNA overexpression early during differentiation
resulted in simplified branching structures, and inhibition by
Anti-miR electroporation resulted in longer neuronal extensions
compared to control cells. These experiments confirm that alteration
of the tightly regulated expression levels of this miRNA affects
the outcome of neural progenitor differentiation.
Conclusions
In summary, these results show that miRNAs are directly implicated
in the differentiation of mouse cortical neural stem cells ex
vivo. The use of optimized miRNA research tools allowed accurate
expression profiling and rapid functional validation of specific
miRNAs. The remaining challenge to determining the precise function
of miRNA is to discover their cellular targets. Dr. Milhavet
and colleagues are currently performing experiments to identify
potential messenger RNAs regulated by the miRNAs identified in
this study.
SuperTaq and SuperTaq Plus are trademarks of and are manufactured
by Enzyme Technologies Ltd. and sold under licensing arrangements
with F. Hoffman-La Roche, Ltd., Roche Molecular Systems, Inc.
and the Perkin-Elmer Corporation. Ambion, Inc. is a distributor
of Enzyme Technologies, Ltd., except in the following countries:
Austria, Benelux, Denmark, Greece, Sweden, Switzerland, Taiwan,
and the United Kingdom.
|